Sentinel lymph node metastases in cancer: Causes, detection and their role in disease progression

Seminars in Cell and Developmental Biology

Volumn 38, Issue , 2015, Pages 106-116

  Nathanson, S D ^a   Shah, R ^a   Rosso, K ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

Lymph node; Metastases; Sentinel

Indexed keywords

CHEMOKINE;

ANGIOGENESIS; CANCER GROWTH; CELL PROLIFERATION; CELL STRESS; HUMAN; LYMPH VESSEL; LYMPHANGIOGENESIS; NEOPLASM; REVIEW; SENTINEL LYMPH NODE METASTASIS; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; IMMUNOLOGY; LYMPHATIC METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; SENTINEL LYMPH NODE BIOPSY;

ANIMALS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; NEOPLASMS; SENTINEL LYMPH NODE BIOPSY; TUMOR MICROENVIRONMENT;

EID: 84928208246     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.10.002     Document Type: Review

References (150)

1. Minn A.J., Massague J. Invasion and metastasis. Cancer: principles and practice of oncology 2008, 117-134. Wolters Kluwer/Lippincott Williams & Wilkins. V.T. DeVita, T.S. Lawrence, S.A. Rosenberg (Eds.).
2. Fidler I.J. Selection of successive tumour lines for metastasis. Nat New Biol 1973, 242:148-149.
3. Nathanson S.D. Preclinical models of regional lymph node tumor metastasis. Cancer metastasis and the lymphovascular system 2007, 129-156. Springer, [Chapter 10]. S.P.L. Leong (Ed.).
4. Jackson D.G., Prevo R., Clasper S., et al. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001, 22:317-321.
5. Stacker S.A., Williams S.P., Karnezis T., Shayan R., Fox S.B., Achen M.G. Lymphangiogenesis and lymphatic vessel remodeling in cancer. Nat Rev Cancer 2014, 14:159-172.
6. Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1:219-227.
7. Virchow R.L.K. Cellular pathology 1860, John Churchill.
8. Halsted W.S. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg 1894, 20:497-555.
9. Halsted W. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907, 46:1-9.
10. Rosenberg S.A. Principles of surgical oncology. Cancer: principles and practice of oncology 2008, 283-293. Wolters Kluwer/Lippincott Williams & Wilkins. V.T. DeVita, T.S. Lawrence, S.A. Rosenberg (Eds.).
11. Urban J.A., Baker H.W. Radical mastectomy in continuity with en bloc resection of the internal mammary lymph node chain: a new procedure for primary operable cancer of the breast. Cancer 1952, 5:992-1008.
12. Weil P.H., Buchberger R. From Billroth to PCV: a century of gastric surgery. World J Surg 1999, 23:736-742.
13. Maruyama K., Okabayashi K., Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987, 11(4):418-425.
14. Piver M.S., Rutledge F., Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstets Gynecol 1974, 44:265-272.
15. Whipple A.O., Parsons W.B., Mullins C.R. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935, 102:763-779.
16. Bland K.I., Menck H.R., Scott-Conner C.E., Morrow M., Winchester D.J., Winchester D.P. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998, 83:1262-1273.
17. Moffat F.L., Senofsky G.M., Davis K., Clark K.C., Robinson D.S., Ketcham A.S. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992, 51(1):8-13.
18. Baclesse F. Roentgen therapy as the sole method of treatment of cancer of the breast. Amer J Roentgen Radium Ther 1949, 62:311-319.
19. Crile G. Treatment of breast cancer by local excision. Amer J Surg 1965, 109:400-403.
20. Gray J.H. The relation of lymphatic vessels to the spread of cancer. Brit J Surg 1939, 26:462-495.
21. Patey D.H., Dyson W.H. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer 1948, 2:7-13.
22. Cabanas R. An approach for the treatment of penile carcinoma. Cancer 1977, 39:456-466.
23. Morton D.L., Hoon D.S., Cochran A.J., Turner R.R., Essner R., Takeuchi H., et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg 2003, 238(4):538-550.
24. Giuliano A.E., Hunt K.K., Ballman K.V., Beitsch P.D., Whitworth P.W., Blumencranz P.W., et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011 Feb 9, 305(6):569-575.
25. Rutgers E.J., Donker M., Straver M.E., Meijnen P., Van De Velde C.J.H. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: final analysis of the EORTC AMAROS trial (10981/22023). J Clin Oncol 2013, 31. suppl; abstr LBA1001.
26. Veronesi U., Viale G., Paganellui G., Zurrida S., Luini A., Galimberti V., et al. Sentinel lymph node biopsy in breast cancer: ten year results of a randomized controlled study. Ann Surg 2010, 251:595-600.
27. Morton D.L., Thompson J.F., Cochran A.J., Mozzillo N., Nieweg O.E., Roses D.F., et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. NEJM 2014, 370:599-609.
28. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
29. Gentilini O., Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast 2012, 21(5):678-681.
30. Karaman S., Detmar M. Mechanisms of lymphatic metastasis. J Clin Invest 2014, 124:922-928.
31. Hoshida T., Isaka N., Hagendoorn J., diTomaso E., Chen Y.L., Pytowski B., et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006, 66:8065-8075.
32. Nathanson S.D., Miller C.G., Paxton J.H. The role of lymphangiogenesis in regional lymph node metastasis: animal models. Current clinical oncology: from local invasion to metastatic cancer 2009, 211-226. Humana Press, [Chapter 19]. S.P.L. Leong (Ed.).
33. Wiley H.E., Gonzalez E.B., Maki W., Wu M-t Hwang S.T. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 2001, 93:1638-1643.
34. Nathanson S.D., Haas G.P., Mead M.J., Lee M. Spontaneous regional lymph node metastases of three variants of the B16 melanoma: relationship to primary tumor size and pulmonary metastases. J Surg Oncol 1986, 33:41-45.
35. Carr I. Lymphatic metastasis. Cancer Met Rev 1983, 2:307-317.
36. Reintgen D., Cruse C.W., Wells K. The orderly progression of melanoma nodal metastases. Ann Surg 1994, 220:759-767.
37. Nathanson S.D., Kwon D., Kapke A., Alford S.H., Chitale D. The role of lymph node metastasis in the systemic dissemination of breast cancer. Ann Surg Oncol 2009, 16:3396-3405.
38. Qian C.N., Berghuis B., Tsarfaty G., Bruch M., Kort E.J., Ditlev J., et al. Preparing the soil: the primary tumor induces vasculature reorganization in the sentinel lymph node before he arrival of metastatic cancer cells. Cancer Res 2006, 66:10365-10376.
39. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
40. Ewing J. Neoplastic diseases 1928, WB Saunders, Philadelphia. 6th Edition.
41. Nathanson S.D. Insights into the mechanisms of lymph node metastasis. Cancer 2003, 98:413-423.
42. Sleeman J.P., Nazarenko I., Thiele W. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer 2011, 128:2511-2526.
43. Shieh A.C. Biomechanical forces shape the tumor microenvironment. Ann Biomed Engin 2011, 39:1379-1389.
44. Quiet C.A., Ferguson D.J., Weichselbaum R.R., Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long term follow-up. J Clin Oncol 1995, 13:1144-1151.
45. Nathanson S.D., Slater R., Kapke A., Burke M. Preoperative identification of the sentinel lymph node. Ann Surg Oncol 2007, 14(11):3102-3111.
46. McDonald D.M. Angiogenesis and vascular remodeling in inflammation and cancer: biology and architecture of the vasculature. Angiogenesis: an integrative approach from science to medicine 2008, 17-33. Springer, [Chapter 2]. W.D. Figg, J. Folkman (Eds.).
47. Le Voyer T.E., Sigurdson E.R., Hanlon A.L., Mayer R.J., MacDonald J.S., Catalano J., et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003, 21:2912-2919.
48. Mohammed R.A.A., Martin S.G., Gill M.S., et al. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Amer J Surg Pathol 2007, 31:1825-1833.
49. CochranA.J.Balda B-R., Starz H., Bachter D., Krag D.N., Cruse C.W., et al. The Augsberg Consensus: techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000, 89:236-241.
50. Hunt K.K., Ballman K.V., McCall L.M., Boughey J.C., Mittendorf E.A., Cox C.E., et al. Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg 2012, 256(3):428-436.
51. Fisher B., Fisher E. Transmigration of lymph nodes by tumor cells. Science 1966, 152(3727):1397-1398.
52. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., Wolmark N. Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 2002, 347:567-575.
53. Fisher B., Wolmark N., Redmond C., Deutsch M., Fisher E.R. Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 1981, 48(8):1863-1872.
54. Cady B. Regional lymph node metastases, a singular manifestation of the process of clinical metastases in cancer: contemporary animal research and clinical reports suggest unifying concepts. Ann Surg Oncol 2007, 14:1790-1800.
55. Folkman J. Proceedings: tumor angiogenesis factor. Cancer Res 1974, 34:2109-2113.
56. Fisher B. Laboratory and clinical research in breast cancer-a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res 1980, 40(11):3863-3874.
57. Hellman S. Natural history of small breast cancers. J Clin Oncol 1994, 12(10):2229-2234.
58. Morikawa S., Baluk P., Kaidoh T., Haskell A., Jain R.K., McDonald D.M. Abnormalities in pericytes on BVs and endothelial sprouts in tumors. Am J Pathol 2002, 160:985-1000.
59. Inai T., Mancuso M., Hashizume H., Baffert F., Haskell A., Baluk P., et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of BM ghosts. Am J Pathol 2004, 165:35-52.
60. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1999, 161:851-858.
61. Shing Y., Folkman J., Sullivan R., Butterfield C., Murray J., Klagsbrun M. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984, 223:1296-1299.
62. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983, 219:983-985.
63. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
64. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182-1186.
65. Folkman J. History of angiogenesis. Angiogenesis: an integrative approach from science to medicine 2008, 1-14. Springer, [Chapter 1]. W.D. Figg, J. Folkman (Eds.).
66. Baluk P., Hashizume H., McDonald D.M. Cellular abnormalities of BVs as targets in cancer. Curr Opin Genet Dev 2005, 15:102-111.
67. Baluk P., Morikawa S., Haskell A., Mancuso M., McDonald D.M. Abnormalities of BM on BVs and endothelial sprouts in tumors. Amer J Pathol 2003, 163:1801-1825.
68. McDonald D.M., Choyke P.L. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003, 9:713-725.
69. Gruber M., Simon M.C. Hypoxia-inducible factors, hypoxia and tumor angiogenesis. Curr Opin Hematol 2006, 13:169-174.
70. Levy A.P., Levy N.S., Goldberg M.A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 1996, 271:2746-2753.
71. Swartz M.A., Lund A.W. Lymphatic and interstitial flow in the tumor microenvironment: linking mechanobiology with immunity. Nat Rev Cancer 2012, 12:210-219.
72. Zlotnik A. Involvement of chemokine receptors in organ specific metastasis. Contrib Microbiol 2006, 13:113-120.
73. Takeuchi H., Fujimoto A., Tanaka M., Yamano T., Hsueh E. Hoon DS.CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Clin Cancer Res 2004, 10:2351-2358.
74. Cueni L.N., Detmar M. Lymphatic vascular system and lymphangiogenesis. Angiogenesis: an integrative approach from science to medicine 2008, 505-516. Springer, [Chapter 43]. W.D. Figg, J. Folkman (Eds.).
75. Achen M.G., McColl B.K., Stacker S.A. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005, 7:121-127.
76. Hirakawa S., Kodama S., Kunsfield R., Kajiya K., Brown L.F., Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005, 201:1089-1099.
77. Butler T.P., Grantham F.H., Gullino P.M. Bulk transfer of fluid in the interstitial compartment of mammary tumors. Cancer Res 1975, 35:3084-3088.
78. Boucher Y., Jain R.K. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992, 52:5110-5114.
79. Nathanson S.D., Nelson L.T. Interstitial fluid pressure in breast cancer, benign breast conditions and breast parenchyma. Ann Surg Oncol 1994, 1:333-338.
80. Witte M.H., Jones K., Wilting J., Dictor M., Seig M., McHale N., et al. Structure function relationships in the lymphatic system and implications for cancer biology. Cancer Met Rev 2006, 25:159-184.
81. Valtola R., Salven P., Heikkila P., Taipale J., Joensuu H., Rehn M., et al. VEGFR3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999, 154:1381-1390.
82. Paavonen K., Puolakkainen P., Jussila L., Jahkola T., Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 2000, 156:1499-1504.
83. Yuan L., Moyon D., Pardanaud L., Bréant C., Karkkainen M.J., Alitalo K., et al. Abnormal lymphatic vessel development in neuropilin-2 mutant mice. Development 2002, 129:4797-4806.
84. Kriehuber J., Breiteneder-Geleff S., Groeger M., Soleiman A., Schoppman S.F., Stingl G., et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001, 194:797-808.
85. Podgrabinska S., Braub P., Velasco P., Kloos B., Pepper M.S., Jackson D.G., et al. Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci U S A 2002, 99:16069-16074.
86. Hirakawa S., Hong Y.K., Harvey N., Schacht V., Matsuda K., Libermann T., et al. Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Amer J Pathol 2003, 162:575-586.
87. Hogan B.M., Bos F.L., Bussmann J., Witte M., Chi N.C., Duckers H.J., et al. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 2009, 41:396-398.
88. Baluk P., Fuxe J., Hashizume H., Romano T., Lashnits E., Butz S., et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007, 204:2349-2362.
89. Nathanson S.D., Avery M., Anaya P., Sarantou T., Hetzel F.W. Lymphatic diameters and lymph clearance rates in a murine melanoma model. Arch Surg 1997, 132:311-315.
90. Avery M., Nathanson S.D., Hetzel F.W. Lymph flow from murine footpad tumors before and after sublethal hyperthermia. Radiat Res 1992, 132:50-53.
91. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO J 2001, 20:672-682.
92. Currie M.J., Hanahan V., Gunningham S.P., Morrin H.R., Frampton C., Han C., et al. Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1a) and the HIF-1a target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. J Clin Pathol 2004, 57:829-834.
93. Starz H., Balda B.R., Kramer K.U., Büchels H., Wang H. A micromorphometric based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001, 91:2110-2121.
94. Diaz L.K., Hunt K., Ames F., Meric F., Kuerer H., Babiera G., et al. Histologic localization of sentinel lymph node metastases in breast cancer. Amer J Surg Pathol 2003, 27:385-389.
95. Lizardo M.M., Macdonald I.C., Tuck A.B., Chambers A.E. A new breast cancer model for lymphatic metastasis. Cancer metastasis and the lymphovascular system: basis for rational therapy 2007, 157-165. Springer. S.P.L. Leong (Ed.).
96. Miteva D.O., Rutkowski J.M., Dixon J.B., Kilarski W., Shields J.D., Swartz M.A. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res 2011, 106:920-931.
97. Tammela T., Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010, 140:460-476.
98. Alitalo K. The lymphatic vasculature in disease. Nature Med 2011, 17:1371-1380.
99. Xu Y., Yuan L., Mak J., Pardanaud L., Caunt M., Kasman I., et al. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol 2010, 188:115-130.
100. Iwasaki T., Takeda Y., Maruyama K., Yokosaki Y., Tsujino K., Tetsumoto S., et al. Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro. J Biol Chem 2013, 208:2118-2131.
101. Fleury M.E., Boardman K.C., Swartz M.A. Autologous morphogen gradients by subtle interstitial flow and matrix interactions. Biophys J 2006, 91:113-121.
102. Jonietz E. The forces of cancer. Nature 2012, 491:S56-S57.
103. Pathak A., Kumar S. Biophysical regulation of tumor cell invasion: moving beyond matrix stiffness. Integr Biol 2011, 3:267-278.
104. Padera T.P., Stoll B.R., Tooredman J.B., Capen D., di Tomaso E., Jain R.K. Cancer cells compress intratumor vessels. Nature 2004, 427:695.
105. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
106. Mitchell M.J., King M.R. Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol 2013, 3:1-11.
107. Nathanson S.D., Mahan M. Sentinel lymph node pressure in breast cancer. Ann Surg Oncol 2011, 18:3791-3796.
108. Nathanson S.D., Shah R., Chitale D.A., Mahan M. Intraoperative clinical assessment and pressure measurements of sentinel lymph nodes in breast cancer. Ann Surg Oncol 2014, 21:81-85.
109. Stelzner F., Steinau H.U., Friedrichs N., von Mallek D. Der Weg regionerer Lymphbahnmetastasen bei Weichgewebssarkomen. Chirurg 2013, 84:502-510.
110. Hanahan D., Weinberg R.A. Hallmarks of cancer; the next generation. Cell 2011, 144:646-674.
111. Starling E.H. On the absorption of fluids from the connective tissue spaces. J Physiol 1896, 19:312-326.
112. Swartz M.A., Iida N., Roberts E.W., Sangaletti S., Wong M.H., Yull F.E., et al. Tumor microenvironment complexity: emerging roles in cancer therapy. Cancer Res 2014, 72:2473-2480.
113. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
114. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2012, 141:52-67.
115. Orimo A., Gupta P.B., Sgroi F., Arenzana-Seisdedos T., Delauney T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2002, 121:335-348.
116. Adams M.J., Jones L., Walker R.A., Pringle J.H., Bell S.C. Changes in tenascin-C isoform expression in invasive and pre-invasive breast disease. Cancer Res 2002, 62:3289-3297.
117. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239-252.
118. Wu Y., Smas C.M. Wdnm-1-like, a new adipokine with a role in MMP-2 activation. Am J Physiol Endocrinol Metab 2008, 295:E205-E215.
119. Yeh Wl Lu D.Y., Fu W.M. Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia 2009, 57:454-464.
120. Pinilla S., Alt E., Abdul Khalek F.J., Jotzu C., Mushberg F., Beckman C., et al. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett 2009, 284:80-85.
121. Heil M., Schaper W. Insights into pathways of arteriogenesis. Curr Pharm Biotechnol 2007, 81:35-42.
122. Davies P.F., Barbee K.A., Violin M.V., Robotewskyj A., Chen J., Joseph L., et al. Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Ann Rev Physiol 1997, 59:527-549.
123. Pierce S.M., Skalak T.C. Microvascular remodeling: a complex continuum spanning angiogenesis to arteriogenesis. Microcirculation 2003, 10:99-111.
124. Ingber D.E. Cellular basis of mechanotransduction. Biol Bull 1998, 194:323-327.
125. Resnick N., Yahav H., Shay-Salit A., Shushy M., Schubert S., Zilberman L.C.M., et al. Fluid shear stress and the vascular endothelium: for better and for worse. Prog Biophys Mol Biol 2003, 81:177-199.
126. Topper N., Gimbrone M.A. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today 1999, 5:40-46.
127. Ng C.P., Hinz B., Swartz M.A. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci 2005, 118:4731-4739.
128. Pedersen J.A., Lichter S., Swartz M.A. Cells in 3D matrices under interstitial flow: effects of extracellular matrix alignment on cell shear stress and drag forces. J Biomech 2010, 43:900-905.
129. De Wever O., Nguyen Q.D., Van Hoorde L., Bracke M., Bruyneel E., Gespach C., et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 2004, 18:1016-1018.
130. Demou Z.N. Gene expression profiles in 3D tumor analogs indicate compressive strain differentially enhances metastatic potential. Ann Biomed Eng 2010, 38:3509-3520.
131. Genis L., Galvez B.G., Gonzalo P., Arroyo A.G. MTI-MMP: universal or particular player in angiogenesis. Cancer Met Rev 2006, 25:77-86.
132. van Hinsbergh V.W., Engelse M.A., Quax P.H. Pericellular proteases in angiogenesis and vasculogenesis. Arteriosler Thromb Vasc Biol 2006, 26:716-728.
133. Cera M.R., Del Prete A., Vecchi A., Corada M., Martin-Padura I., Motoike T., et al. Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest 2004, 114:729-738.
134. Das S., Sarrou E., Podgrabinska S., Cassella M., Mungamuri S.K., Feirt N., et al. Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses. J Exp Med 2013, 210(8):1509-1528.
135. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
136. Padera T.P., Kadambi A., di Tomaso E., Carreira C.M., Brown E.B., Boucher Y., et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296:1883-1886.
137. He Y., Rajantie I., Pajusola K., Jeltsch M., Holopainen T., Yla-Herttuala S., et al. Vascular endothelial growth factor receptor 3 mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 2005, 65:4739-4746.
138. Skobe M., Hamberg L.M., Hawighorst T., Schirner M., Wolf G.L., Alitalo K., et al. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Amer J Pathol 2001, 159:893-903.
139. Wang W., Gosswami S., Sahai E., Wyckoff J.B., Segall J.E., Condeelis J.S. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005, 15:138-145.
140. Condeelis J., Segall J.E. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003, 3(12):921-930.
141. Wyckoff J., Wang W., Lin E.Y., Wang Y., Pixley F., Stanley E.R., et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004, 64(19):7022-7029.
142. Yamaguchi H., Wyckoff J., Condeelis J. Cell migration in tumors. Curr Opin Cell Biol 2005, 17(5):559-564.
143. Weaver Am Page J.M., Guelcher S.A., Parekh A. Synthetic and tissue derived models for studying rigidity effects on invadopodia activity. Methods Mol Biol 2013, 1046:171-189.
144. Harrell M.I., Iritani B.M., Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007, 170:774-786.
145. Hirakawa A. From tumor lymphangiogenesis to lymphovascular niche. Cancer Sci 2009, 100:983-989.
146. Cochran A.J., Morton D.L., Stern S., Lana A.M.A., Essner R., Wen D.R. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 2001, 14:604-608.
147. Fisher B., Fisher E.R. Significance of the interrelationship of the lymph and blood vascular systems in tumor cell dissemination. Prog Clin Cancer 1970, 4:84-96.
148. Van Zee K.J., Manasseh D.M.E., Bevilacqua J.L., Boolbol S.K., Fey J.V., Tan L.K., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003, 10:1140-1151.
149. Jain R.K., Padera T.P. Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. J Natl Cancer Inst 2002, 94:785-787.
150. Jain R.K., Martin J.D., Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng 2014, 16:321-346.